Home tDCS for the Treatment of Major Depression. (NCT07510880) | Clinical Trial Compass
RecruitingNot Applicable
Home tDCS for the Treatment of Major Depression.
Spain198 participantsStarted 2026-04-14
Plain-language summary
The purpose of this multicentric randomized controlled trial is to compare the effectiveness and safety of home-based tDCS for the treatment of major depression versus tDCS treatment in a healthcare centre, and explore the effects of an accelerated home-tDCS protocol.
The change in depression index at the end of treatment, measured with MADRS, will be the primary outcome.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Spanish or Catalan speakers of both sexes between the ages of 18 and 65.
* Patients diagnosed with major depression, based on the criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Specifically, patients will be included who meet the criteria for a major depressive episode with a longitudinal diagnosis of major depressive disorder, single or recurrent episode; or bipolar disorder type 1 or 2. Patients must obtain a moderate or higher score, therefore we establish a lower limit of 15 points on the Montgomery-Ã…sberg Depression Rating Scale (MADRS) (Alonzo et al., 2019).
* Patients receiving or not receiving pharmacological treatment for depression will be included, and this will be recorded as an additional variable.
* Have the ability and willingness to commit to the study team for supervision of the intervention sessions and close monitoring of safety.
* Demonstrate the acquisition of the ability to properly apply home tDCS independently or with the help of a companion.
Exclusion Criteria:
* Patients with psychotic, schizoaffective, or personality disorders (both cluster A and B).
* Patients with a history of neurological disease, intellectual disability, or cognitive impairment (inability to understand instructions or operate equipment).
* Any exclusion criteria established by clinical guidelines on non-invasive brain stimulation (Woods et al., 2016): metal implants or head injuries, any electronic devices such as cochlear…
What they're measuring
1
MADRS
Timeframe: End of treatment: 3 week for Accelerated home-tDCS arm; 9 week for Conventional home-tDCS and ambulatory tDCS arm.